Guidelines: Difference between revisions
Jump to navigation
Jump to search
Urology4all (talk | contribs) No edit summary |
|||
| Line 37: | Line 37: | ||
==== Functional ==== | ==== Functional ==== | ||
* Management of LUTS Attributed to BPH (2021) | * [[AUA: Management of LUTS Attributed to BPH (2021)|Management of LUTS Attributed to BPH (2021)]] | ||
*[[AUA & CUA Mesh Position Statement (2019)|AUA/CUA Mesh Position Statement (2019)]] | |||
* [[AUA: Incontinence after Prostate Therapy (2019)|Incontinence after Prostate Therapy (2019)]] | |||
*[[AUA: Surgical Management of LUTS due to BPH (2018)|Surgical Management BPH (2018)]] | *[[AUA: Surgical Management of LUTS due to BPH (2018)|Surgical Management BPH (2018)]] | ||
* [[AUA: Female SUI (2017)|Female SUI (2017)]] | * [[AUA: Female SUI (2017)|Female SUI (2017)]] | ||
| Line 64: | Line 64: | ||
* Interstitial cystitis/bladder pain syndrome (2022) | * Interstitial cystitis/bladder pain syndrome (2022) | ||
*Infertility (2021) | |||
* Infertility (2021) | |||
* Priapism (2021) | * Priapism (2021) | ||
*Neurogenic LUTD (2021) | *Neurogenic LUTD (2021) | ||
Revision as of 12:59, 23 March 2023
AUA Guidelines
Oncology
Prostate
- Clinically Localized Prostate Cancer (2022)
- Advanced Prostate Cancer (2020)
- Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
- Prostate Cancer Screening (2018)
- Clinically Localized Prostate Cancer (2017)
Bladder
- Muscle-invasive Bladder Cancer (2020)
- Non-muscle Invasive Bladder Cancer (2020)
- Microscopic Hematuria (2020)
- Muscle-invasive Bladder Cancer (2017)
- Non-muscle Invasive Bladder Cancer (2016)
Kidney
Testicular
- (2019) Included in Testicular Tumours Chapter Notes
Non-oncology
Andrology
Functional
- Management of LUTS Attributed to BPH (2021)
- AUA/CUA Mesh Position Statement (2019)
- Incontinence after Prostate Therapy (2019)
- Surgical Management BPH (2018)
- Female SUI (2017)
Infections and Inflammation
Pediatrics
Stones
Other
Contribute
- Interstitial cystitis/bladder pain syndrome (2022)
- Infertility (2021)
- Priapism (2021)
- Neurogenic LUTD (2021)
- Disorders of ejaculation (2020)
- OAB (2019)
- Antibiotic Prophylaxis (2019)
- Cryptorchidism (2018)
CUA Guidelines
Oncology
Prostate
- Castrate-resistant Prostate Cancer (2021)
- Androgen Deprivation Therapy: Adverse Events & Management (2021)
- Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
- Testosterone Suppression (2018)
- Prostate Cancer Screening (2017)
- Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
- Prostate Cancer Active Surveillance (2015)
Bladder
- Non-muscle Invasive Bladder Cancer (2021)
- Advanced and Metastatic Urothelial Cancer (2019)
- Muscle-invasive Bladder Cancer (2019)
- Asymptomatic Microscopic Hematuria (2008)
Kidney
- Follow-up Localized RCC (2018)
- Cystic Renal Lesions (2017)
- Small Renal Masses (2015)
- Surgical Management of RCC (2014)
- RCC Genetic Screening (2013)
Non-oncology
Andrology
Functional
- Neurogenic Lower Urinary Tract Dysfunction (2019)
- Male LUTS/BPH (2018)
- CUA/AUA Mesh Position Statement (2019)
- Overactive Bladder (2017)
Infections and Inflammation
- CUA/AUA Recurrent UTI (2019)
- Antibiotic Prophylaxis (2015)
- Chronic Scrotal Pain (2018)
- Interstitial Cystitis (2016)
Infertility
Pediatrics
- Circumcision (2018)
- Antenatal hydronephrosis (2017)
- Cryptorchidism (2017)
- Multicystic Dysplastic Kidney in the Neonate (2015)
Stones
Other
- Vasectomy (2016)
- Adrenal Mass (2011)
- Radiation-induced Hemorrhagic Cystitis (2018)
- VTE Prophylaxis (2019)
Contribute
- Ureteral calculi (2022)
- Pediatric bladder dysfunction (2021)
- Sporadic angiomyolipomas (2020)
- Male urethral stricture (2020)
- Catheter use (2020)
- Renal mass biopsy (2019)
- Pheochromocytoma surveillance (2019)
- Pediatric hemorrhagic cystitis (2019)